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Cigarette smoking by adolescents is arguably
one of the most important public health prob-
lems of our time. The percentage of U.S. high
school students who smoke rose by nearly
one-third between 1991 and 1997 (1),
although it has decreased somewhat since
then. A prospective 3-year survey of 401 U.S.
children also found that 217 (54%) tried
smoking in grades 5–7 (10–13 years of age).
In this study, 63 students smoked throughout
the 3 years of the study, with 90 trying smok-
ing in the fifth or sixth grade but stopping by
seventh grade, and 64 starting in the last year
of the study (seventh grade) (2). Recent work
now indicates the clinical effects of these
trends in smoking initiation: national cancer
surveillance data show a birth cohort pattern
of lung cancer mortality after 1950 that
reflects the impact of teenage cigarette smok-
ing in people younger than 45 years of age (3).
A feature of early smoking that is only
now emerging from basic molecular research
is the relationship between tobacco-induced
changes in the constitution of lung cells and
their subsequent increased susceptibility to
malignant transformation. Smoking-related
genetic alterations of the respiratory epithe-
lium occurring in early life may be responsi-
ble for the epidemiologic observations which
suggest that early smoking initiation confers
an increased lung cancer risk independent of
years of smoking duration or smoking inten-
sity (4–7). Gender-related differences in
lung development may also be linked to
epidemiologic observations that women and
men differ in lung cancer risk at a given level
of smoking (8,9). In this paper, we propose
that normal developmental processes, in
concert with exposure to tobacco smoke,
may promote an abnormal clonal prolifera-
tion initiating a process termed “field cancer-
ization.” Abnormal clonal fields caused by
early smoking may become the fertile
ground for the emergence of potentially
lethal cancers later in life.
Human Lung Development
The human lung and airways are known to
undergo a complex development. At birth the
lung contains somewhere between 17 and 70
million alveoli (10). By 7 years of age, a 13-
fold increase in lung volume has taken place
(11), and in adult lungs, individual alveoli
number some 200–600 million. The rate of
lung growth, measured by volume, is thought
to be linear from birth to approximately
11–12 years of age (with females having a
slightly earlier end to the rapid, linear phase of
growth in volume) (12). The onset of puberty
coincides with dramatic changes in lung func-
tion. Sudden increases in spirometric lung
function at the pubertal growth spurt have
been recorded for each sex (13). Airways in
females may be larger than in males before
puberty (11), but during and after puberty air-
way size relative to lung size in boys increases
beyond that in girls (14). Hence, growth of
airways and parenchyma appears to be propor-
tional in females, but in males large airway
growth lags behind growth of the parenchyma
(11). Tager et al. (12) have shown that males
reach a plateau in lung volume sometime after
24 years of age (slow, continued growth may
persist through the early 30s), whereas females
reach their maximum growth earlier, at
approximately 18 years of age.
Cigarette smoking in adolescence exacer-
bates respiratory ailments and also alters the
growth of lung volume. The linear phase of
growth in lung volume is approximately 1 year
shorter in males who smoke compared with
those who never smoked and 2–3 years shorter
in female smokers (12). Gold et al. (15) fur-
ther showed that the plateau level in lung vol-
ume reached by smokers is less than that of
nonsmokers. These data show that tobacco
smoking diminishes the rate of growth of the
lungs when exposure occurs before the age at
which growth plateaus (18 years of age in
females and approximately 24 years of age in
males). The mechanism responsible for this
drop in the rate of growth is unknown; how-
ever, tobacco-related killing of dividing cells
and their replacement through a process anal-
ogous to wound healing is almost certain to
take place in the airways and throughout the
lung. Amid this interplay of developmentally
programmed cell proliferation, genotoxic
exposure and wound healing may give rise to
the conditions for the pathologic process
termed “cancerization of cellular fields.”
Field Cancerization
Slaughter et al. (16) first articulated the
explicit concept of “field cancerization” in
1953 based on observations of the occur-
rence of multiple primary tumors in the
same tissue in proximity to each other.
Slaughter et al. (16) reported that grossly
normal epithelium can be “preconditioned”
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Cigarette smoking by children and adolescents continues to be prevalent, and this fact represents
a major public health problem and challenge. Epidemiologic work has previously suggested that
exposure of the lung to tobacco carcinogens at an early age may be an independent risk factor for
lung cancer. Recent studies at the molecular and cellular levels are consistent with this, now sug-
gesting that early exposure enhances DNA damage and is associated with the induction of DNA
alterations in specific chromosomal regions. In this paper we hypothesize that adolescence, which
is known to be the period of greatest development for the lung, may constitute a “critical period”
in which tobacco carcinogens can induce fields of genetic alterations that make the early smoker
more susceptible to the damaging effects of continued smoking. The fact that lung development
differs by sex might also contribute to apparent gender differences in lung cancer susceptibility.
Because this hypothesis has important implications for health policy and tobacco control, addi-
tional resources need to be devoted to its further evaluation. Targeted intervention in adolescent
smoking may yield even greater reductions in lung cancer occurrence than otherwise anticipated.
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by carcinogen exposure; this is consistent
with the hypothesis that early tobacco-
induced somatic mutations are propagated by
enhanced cell replication into a clonal “field”
of genetically altered progenitor cells. Recent
work has shown that large clones of somati-
cally altered cells (e.g., 90,000 cells) can be
found in grossly normal lung tissue after
resection for lung cancer or after biopsy of
normal tissue in the airways of smokers
(17,18). In fact, it has been repeatedly shown
that fields of cells containing loss of heterozy-
gosity (deletion of one copy of allelic DNA
sequences) within the chromosome 3p21.3
region are among the earliest and most fre-
quent events found in normal-appearing tis-
sues in the lungs of smokers and in the lung
cancers of smokers (particularly for the squa-
mous histology) (17–20). This loss is fre-
quent among clonal outgrowths and has been
observed in the lungs of very young smokers
with normal airways (17). Furthermore,
Franklin et al. (21) showed that large patches
of cells (extending into the lower lobe
bronchi of both lungs) within grossly nor-
mal-appearing lung epithelium can contain a
single somatically arising p53 mutation, thus
strongly implicating a developmentally early
clonal process. Taken together, these observa-
tions demonstrate that the induction by
tobacco carcinogens of fields of somatically
altered cells is a frequent and perhaps ordered
feature of lung cancer. Interestingly, carcino-
gen exposure that occurs at a young age is
hypothesized to be an independent cancer
risk factor for tumors arising in other tissues
displaying field cancerization; cutaneous
exposure to ultraviolet light in children is
known to independently enhance risk of
melanoma in adulthood (22–24), and ioniz-
ing radiation exposures during puberty (from
Hiroshima and Nagasaki atomic bomb
explosions) enhanced breast cancer risk in
Japanese (25). Hence, tobacco carcinogen
exposure of growing lungs could quite plausi-
bly have a far greater likelihood of producing
larger, more biologically significant clonal
expansions compared with exposures that
occur after lung growth has slowed or ceased.
The links between these somatic alter-
ations in the lung and early smoking initia-
tion have come very recently. We (26,27)
and others (28) have observed associations of
tobacco-related DNA damage and muta-
tional changes with self-reported age at
smoking initiation in patients with lung can-
cer. Most significantly, younger ages of
smoking initiation were associated with a
higher prevalence of chromosomal deletions
within the specific genomic region impli-
cated in field cancerization in the lung (i.e.,
3p21). The highest prevalence of 3p21 loss
occurred in lung cancer patients who
reported smoking before 16.5 years of age
(27). By this time in life, advanced Tanner
pubertal stages are recorded in almost all
persons and most boys and girls will have
undergone their maximal growth spurt.
These associations lead to a novel hypothe-
sis: Growth and development of the lungs
during adolescence may set up a critical
period of susceptibility to tobacco-related
DNA damage. Because lung development
proceeds through the teen years, exposure to
tobacco carcinogens during this period may
lead to the propagation of fields of altered
epithelial cells, particularly in the airway, that
later evolve into frank malignancy. Exposure
after the critical growth period may have a
much lower probability of inducing large,
clonal outgrowths with the same malignant
potential. The elements of this developmental
hypothesis are summarized in Table 1. That
these mechanisms operate to create a critical
period of tobacco susceptibility in adolescence,
however, is only a hypothesis. Ours were
cross-sectional observations based on self-
reported age of smoking initiation among per-
sons who developed lung cancer and should
be interpreted with caution until confirmed.
The Future
Traditional epidemiologic methods have pro-
vided limited insight into the important
question of age at smoking initiation and
lung cancer risk. A younger age of starting to
smoke, by increasing duration of smoking at
any particular age, is, of course, predicted to
increase lung cancer risk. There is limited
epidemiologic evidence that age at onset of
smoking independently confers an increase in
cancer risk (29,30). It has been very difficult
to disentangle the effects of age at smoking
initiation from those of smoking duration
and intensity, especially among current
smokers. With the growing population of
former smokers, however, this question can
now be revisited with better prospects for
identifying age-specific risks. Also, early
smoking may affect specific subtypes of lung
cancer. Much of the molecular evidence sup-
porting early field cancerization is drawn
from studies of the proximal airways accessi-
ble to the bronchoscope where squamous
cell carcinomas most frequently arise. Less
evidence is available to address this process
in other cell types in the periphery of the
lung. If subtype specificity does exist, the
independent effect of early smoking on lung
cancer would be considerably more difficult
to detect in the many epidemiologic studies
that have grouped different histologies
together. In addition, because adenocarci-
noma is becoming increasingly prevalent,
this may produce conflicting results between
older and more recent studies of this ques-
tion, absent adjustment for histologic sub-
type of cancer. Furthermore, early smoking
may be associated with competing risks that
could obscure the effects of smoking initia-
tion on lung cancer risks. For example, in
the Nurses Health Study, women who
started smoking before 15 years of age expe-
rienced significantly greater risks for cardio-
vascular mortality compared with women
who started smoking later in life (31).
In the future, how can we bring into
focus the unique physiologic and toxicologic
dimensions of youth smoking and lung can-
cer so that we can judge their real clinical and
public health importance? One way is to con-
tinue to investigate the molecular epidemiol-
ogy of lung cancer and reinforce the links
between cancerous somatic mutations and
early smoking. This requires the standardized
collection of detailed smoking histories from
lung cancer patients and their integration
with molecular information derived from
high-density genetic maps of chromosomal
loss occurring within patients’ lung tumors.
The search for progressively more precise
physical mapping of the regions of chromo-
some 3p21 associated with early smoking
initiation is an extension of ongoing somatic
linkage analyses to identify putative lung
tumor suppressor genes using lung cancer cell
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Table 1. Evidence supporting a critical period for the induction of lung cancer.
Type of evidence Description of evidence Reference
Epidemiologic Age at onset of cigarette smoking is a risk factor for lung cancer (4–7)
Women may be at higher risk compared with men (8,9)
Developmental Lung volumes increase significantly during the adolescent growth spurt (11,13)
Respiratory airways in girls mature faster compared with boys (11,12,14)
Cellular Fields of genetically altered cells are induced by exposure to tobacco smoke (16–20)
Clonal expansion of abnormal fields may be augmented by developmentally programmed cell proliferation (22–25)
Molecular The earliest genetic changes in lung cancer occur in highly fragile chromosomal sites, including the 3p21 region (17,18)
Deletions of 3p21 occurred most frequently in lung cancers from persons who started smoking early in adolescence (27)
DNA damage within the lung is increased in smokers who started smoking early in adolescence (26,28)
lines (32). The possibility that a heightened
sensitivity to chromosomal loss may accom-
pany exposures around puberty serves to
emphasize the importance of these investiga-
tions. At least 25 gene candidates have been
identified within the 630-kb homozygous
deletion region that is thought to harbor one
or more genes critical in lung cancer. In the
present context, however, it must be empha-
sized that the linkage under scrutiny is not
cancer per se but cancer arising after a devel-
opmentally specific exposure to tobacco car-
cinogens. Hence, we have no a priori reason
to suppose that the ongoing search within the
3p region for lung cancer suppressor genes
and the search for genes conferring increased
risk by smoking at an early age will converge
on the same gene(s). Interestingly, the 3p21
marker we found associated with early smok-
ing in our studies (D3S1478) maps to a loca-
tion about 1.5 Mb telomeric to the
aforementioned commonly deleted region.
Finally, we must add that, aside from the
specific genes involved in the critical early
stages of lung cancer, we still do not under-
stand the basis for the intrinsic chromosomal
instability of the 3p region. The fragility of
the region contributes to many cancers in
addition to lung cancer. Curiously, in any
one patient, this instability affects one
parental allele preferentially, a phenomenon
referred to as allele-specific mutation (17).
We need clinical and population scientists
to clarify how researchers will refine the
assessment of lung development on the one
hand and more precisely quantify early smok-
ing initiation on the other. Our understand-
ing of adolescent lung development is based
on an extensive body of functional studies.
This must be contrasted with the principal
mechanism driving the process of field can-
cerization, which is most likely increased cell
proliferation within a relatively small progeni-
tor epithelial cell compartment. Clearly, we
need more research documenting the cellular
correlates of spirometric measures of growth
in lung function and addressing both unex-
posed and tobacco-exposed conditions.
As for smoking exposure assessments, it is
critical to recognize that multiple patterns of
smoking initiation occur (2). We often assume
that smoking initiation occurs in uniform
stages; initiation involves an early experimen-
tation stage characterized by intermittent and
low tobacco exposures; subsequently, a period
of more regular cigarette consumption ensues,
and later a “ramping up” of daily consump-
tion may take place. What are the most signifi-
cant parameters to focus on that will yield the
most sensitive measure of a heightened devel-
opmental susceptibility to tobacco damage?
Studies by Gold et al. (15) indicated that
smoking five or more cigarettes per day was
associated with decrements in lung function
in boys and girls. In our studies, we took the
age of smoking initiation to be the age at
which patients reported daily smoking of
any number of cigarettes. Also, because the
physiologic effects of puberty must be
addressed, the fact that the age of onset of
puberty is highly variable among individuals
requires even further scrutiny of our expo-
sure measurement tools. The timing of
puberty varies by sex and perhaps ethnicity,
and it may be undergoing long-term secular
change. The foregoing challenges illustrate
that new instruments must be developed and
validated before the most optimal tests of the
existence of a “critical period” for suscepti-
bility to lung cancer can take place.
Examination of the hypothesis put forth
here also may have implications for tobacco
control policy. The consequences of increas-
ing our knowledge in addressing these now-
critical questions are clear; if exposure to
tobacco smoke before the lung is develop-
mentally mature represents a “critical
period” resulting in enhanced, independent
cancer risk, stopping cigarette smoking in
adolescents takes on vital new importance.
Those involved in the crucial area of
tobacco-associated cancer prevention should
be encouraged by the knowledge that delay-
ing teen smoking by even 1–2 years may
result in an important reduction in lung can-
cer risk. Programs aimed at early smoking
prevention should be encouraged because
they will clearly reap real rewards.
Furthermore, in the current environment
of renewed attention to tobacco-associated
cancer prevention, we should appreciate that
knowledge of this sort is crucial to public
health. Now is the time to turn the tools of
the laboratory and the epidemiologist more
generally on this question and others like it.
These tools are a vital part of the prevention
enterprise and must be recognized as such by
the public health community and basic and
applied scientists. Ultimately, we share the
common goal of understanding this disease
and using this knowledge to benefit all of us.
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